Effects of two different reversible monoamine oxidase-A inhibitors on nociceptive thresholds in the rat

Eur J Pharmacol. 1992 Aug 14;219(1):113-6. doi: 10.1016/0014-2999(92)90587-t.

Abstract

The acute effect of two different reversible inhibitors of monoamine oxidase-A on nociceptive thresholds was evaluated in the rat by the tail-flick and hot-plate tests. CGP 11305-A, a monoamine oxidase-A inhibitor that also blocks serotonin reuptake, elicited an increase of latency in the tail-flick and the hot-plate test. Ineffective doses of CGP 11305-A increased nociceptive thresholds when administered in combination with other serotoninergic agents, i.e. chlorimipramine or 5-hydroxytryptophan, at doses that were ineffective alone. CGP 22364-A, a pure inhibitor of monoamine oxidase-A, increased latency only in the hot-plate test. Both compounds decreased spontaneous locomotor activity at the doses effective in the hot-plate test, suggesting that the responses observed in this test are not related to a pure effect on nociceptive thresholds. The data suggest that the increase in serotonin availability induced by monoamine oxidase-A inhibition alone is not sufficient to affect nociceptive thresholds.

MeSH terms

  • Animals
  • Male
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Pain / physiopathology*
  • Piperidines / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Sensory Thresholds / drug effects*
  • Serotonin / metabolism

Substances

  • Monoamine Oxidase Inhibitors
  • Piperidines
  • Serotonin
  • brofaromine